163496-06-8

Usage

Uses

Used in Pharmaceutical Industry:
Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2-thiois used as a research compound for its potential pharmacological applications in neuroscience and neuropharmacology. The presence of the 2-thio group may enhance its biological activity or binding properties, making it a promising candidate for the development of new drugs targeting neurological disorders and conditions.
Used in Research and Development:
Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2-thiois used as a research tool to explore its full potential and applications in various fields related to human health and medicine. Further studies and research are needed to elucidate its specific biological activity, binding properties, and potential therapeutic effects, which could lead to the discovery of novel treatments and interventions for a range of health issues.

Upstream product

• 40615-36-9 4,4'-dimethoxytrityl chloride 
• 20235-78-3 2-thiouridine 

Downstream Products

• 1384570-85-7 5′-O-(4,4′-dimetoxytrityl)-2′-O-tert-butyldimethylsilyl-2-selenouridine 
• 1384570-88-0 C₃₆H₄₄N₂O₇SeSi 
• 1384570-93-7 C₃₉H₄₇N₃O₇SeSi 
• 1384570-90-4 C₃₉H₄₇N₃O₇SeSi 
• 1262964-71-5 C₄₈H₆₄N₅O₈PSeSi 
• 1384570-81-3 C₃₁H₃₂N₂O₇S 
• 1384570-83-5 5'-O-dimetoxytrityl-2-selenouridine 
• 1627601-87-9 5'-O-dimethoxytrityl-S-geranyl-2-thiouridine 

Relevant academic research and scientific papers

S-Geranyl-2-thiouridine wobble nucleosides of bacterial tRNAs; Chemical and enzymatic synthesis of S-geranylated-RNAs and their physicochemical characterization

Recently, highly lipophilic S-geranylated derivatives of 5-methylaminomethyl-2-thiouridine (mnm5geS2U) and 5-carboxymethylaminomethyl-2-thiouridine (cmnm5geS2U) were found at the first (wobble) anticodon position in bacterial tRNAs specific for Lys, Glu and Gln. The function and cellular biogenesis of these unique tRNAs remain poorly understood. Here, we present one direct and two post-synthetic chemical routes for preparing model geS2U-RNAs. Our experimental data demonstrate that geS2U-RNAs are more lipophilic than their parent S2U-RNAs as well as non-modified U-RNAs. Thermodynamic studies revealed that the S-geranyl-2-thiouridine-containing RNA has higher affinity toward complementary RNA strand with G opposite the modified unit than with A. Recombinant tRNA selenouridine synthase (SelU) exhibits sulfur-specific geranylation activity toward model S2U-RNA, which is composed of the anticodon-stem-loop (ASL) from the human tRNALys3 sequence. In addition, the presence of magnesium ions is required to achieve appreciable geranylation efficiencies.

Transformation of a wobble 2-thiouridine to 2-selenouridine via S-geranyl-2-thiouridine as a possible cellular pathway

The newly discovered S-geranylated 2-thiouridines (geS2U) (Dumelin et al., 2012) and 2-selenouridines (Se2U) were recently shown to be synthesized by a single enzyme (selenouridine synthase, SelU) through two distinct pathways using the same 2-thiouridine substrate (S2U); however, no clear catalytic mechanism was proposed. We suggest that S-geranyl-2-thiouridine is an intermediate of the SelU-catalyzed conversion of S2U to Se2U. The successful chemical transformation of S2U → geS2U → Se2U is demonstrated here as an initial approximation of the intracellular pathway. The structure of Se2U was confirmed by spectroscopic methods, which included, for the first time, 77Se NMR data (δ 354 ppm).2014 Elsevier Inc. All rights reserved.